AFC Agro Biotech Limited announcements
258 Dhaka Stock Exchange announcements for AFC Agro Biotech Limited (AFCAGRO) since 2014: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (11).
- The company has informed that it has entered into an agreement with Bioneer Corporation, a South Korean company speciali
The company has informed that it has entered into an agreement with Bioneer Corporation, a South Korean company specializing in molecular diagnostics, to produce a range of molecular diagnostic kits for the detection of Dengue, Chikungunya, Hepatitis B virus, Hepatitis C virus, HPV, HLab27, TB, STI, GI, and transplant-related viruses, etc. Under the agreement, AFC Agro Biotech Limited will manufacture, refill and distribute Bioneer\'s molecular diagnostic kits in Bangladesh (cont.)
- (Cont. news of AFCAGRO): and other ASEAN countries. The kits will be used to diagnose a wide range of infectious disease
(Cont. news of AFCAGRO): and other ASEAN countries. The kits will be used to diagnose a wide range of infectious diseases, including those that are currently difficult or expensive to diagnose. (end)
The first part of this announcement is missing from the archive. - (Q3 Un-audited): EPS was Tk. 0.01 for January-March 2023 as against Tk. 0.05 for January-March 2022; EPS was Tk. 0.17 fo
(Q3 Un-audited): EPS was Tk. 0.01 for January-March 2023 as against Tk. 0.05 for January-March 2022; EPS was Tk. 0.17 for July 2022-March 2023 as against Tk. 0.39 for July 2021-March 2022. NOCFPS was Tk. 0.36 for July 2022-March 2023 as against Tk. (0.90) for July 2021-March 2022. NAV per share was Tk. 18.33 as on March 31, 2023 and Tk. 19.96 as on June 30, 2022. (cont.)
- Q3 Financials
(Continuation news of AFCAGRO): Reasons for deviation in EPS: EPS has been decreased due to decrease in profit from comparative quarter. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 25, 2023 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.02 for October-December 2022 as against Tk. 0.04 for October-December 2021; EPS was Tk. 0.16 for July-December 2022 as against Tk. 0.33 for July-December 2021. NOCFPS was Tk. 0.32 for July-December 2022 as against Tk. 0.53 for July-December 2021. NAV per share was Tk. 18.32 as on December 31, 2022 and Tk. 18.19 as on June 30, 2022.
- Sale and Buy Confirmation of a Sponsor and a Corporate Director
Md. Sayadur Rahman, one of the Sponsors of the Company, has further informed that he has completed his sale of 25,46,277 shares whereas AFC Capital Limited, a Corporate Director of the company, has also informed that it has completed its buying of 25,46,277 shares at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 24.01.2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 5:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
- Sale and Buy Declaration of a Sponsor and a Corporate Director
Md. Sayadur Rahman, one of the Sponsors of the Company, has expressed his intention to sell his entire holding 25,46,277 shares (in the Block Market) whereas AFC Capital Limited, a Corporate Director of the company, has expressed its intention to buy 25,46,277 shares at prevailing market price (in the Block Market) through Dhaka Stock Exchange within next 30 working days.
- Transfer of shares outside the Trading System of the Exchange
Dhaka Stock Exchange Limited (DSE) has accorded its consent to transfer 28,18,500 shares of AFC Agro Biotech Ltd. outside the trading system of the exchange from Active Fine Chemicals Ltd. (the transferor), one of the Sponsors of the Company to Dhaka Bank Limited, Banani Branch (the transferee) within 30 working days from the date of issuance of approval letter by DSE, under Regulation - 47 of the Dhaka Stock Exchange (Listing) Regulations, 2015.
- National Credit Ratings Limited (NCR) has announced the surveillance entity rating of the Company as \"A\" in the long t
National Credit Ratings Limited (NCR) has announced the surveillance entity rating of the Company as \"A\" in the long term and \"ST-3\" in the short term along with developing outlook based on audited financial statements as on June 30, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.